My ambulance crew is forced to put a plaster over society"s failure

However good the NHS is, it is not a lot of things; it isn’t social care, it isn’t a hotel and it most certainly isn’t a miracle worker. I work as an emergency care assistant on ambulances at the weekend. I can see the amazing things the health service does, but also why it sometimes appears to be falling apart at the seams. The NHS is stretched to breaking point every day. There are a lot of reasons for this and some of them are easy to see.

I’ve lost count of the number of times I have been called to patients who aren’t really patients at all. They are desperately in need of help, but not medical help. They need social care. Or social housing. They need their basic needs to be met, but not an ambulance crew. It’s just that there is no one else who they can call on a Sunday afternoon when, for example, they are at the end of their tether. When the loneliness hits hard, the prospect of not seeing a friendly face for another week is more than they can bear.

In the past this would have been dealt with by ringing another family member, or by a carer or a respite centre to give the family a break. These days, though, families are spread far apart and cuts to local authority budgets mean social care has been decimated. There is no one to call. There is no relief or respite in sight for a lot of these people and so, in desperation, they call an ambulance.

In turn, because the ambulance crew can see that the family cannot cope, that it’s just too much, we have no choice. We take them to hospital in the hope that given a few hours of space the family feels better, more able to continue in the thankless task of caring. We put a plaster over society’s failure.

And so there goes a hospital bed. A nurse, a doctor, all of whose time is taken up, instead of looking after the sick. There goes the protected NHS budget – the one that the government has pledged to increase. Only it’s not really an increase or protected at all, because now, instead of the money being spent on social care, and coming out of local authority budgets, it is coming out of the NHS one.

Then there are the lost souls. Those who drift, who sofa surf or sleep on park benches. Many of them mentally unwell but not acutely so. They don’t need a hospital, they just need somewhere warm and safe. It takes a cold-hearted person to leave someone on a park bench when you know they have nowhere else to go and it is -3C outside. Yet again we, the ambulance crew, paid for by the NHS, spend our time and your money phoning around charities, forgotten contacts in our patient’s phone, in the hope that we can find them a warm bed for the night. If not, due to cuts in social housing, there being no easy access hostels, we take them to the warm waiting room of the hospital. As we sit there sticking plasters on the plight of the homeless, another cardiac arrest call goes unanswered. Another person dies.

Other patients are just too old; their bodies far too weak. Sometimes it happens slowly, other times it is quick. I recently went to a patient who was in his 90s and barely lucid. His daughter insisted he had been fine until he got pneumonia and was taken into hospital for a month.

There was no point telling her that maybe it was just his time to go. That he had lived longer than most people, that the hospital she was blaming for the state of her father was probably to blame, only not in the way that she thought. Years ago, her dad wouldn’t have been taken to hospital to be treated for the pneumonia that nearly killed him. He would likely have just died at home. Instead we dragged him off to A&E for more interventions. When he isn’t restored back to full health, no doubt his daughter will claim that the hospital killed him. Blame, it would seem, is easier than the truth. Sometimes we just need to allow people to die and not play God and attempt miracles.

If you would like to write a blogpost for Views from the NHS frontline, read our guidelines and get in touch by emailing sarah.johnson@theguardian.com.

Join the Healthcare Professionals Network to read more pieces like this. And follow us on Twitter (@GdnHealthcare) to keep up with the latest healthcare news and views.

My ambulance crew is forced to put a plaster over society"s failure

Labour’s failure on the NHS is prolonging this health crisis | Polly Toynbee

Remember Mavis Skeet? In 2000 the 74-year-old led the news for weeks when her operation for cancer of the oesophagus was cancelled four times, until it became inoperable and she died. Liam Fox, then shadow health secretary, exclaimed: “This is not an isolated case. The NHS is not coping!”

When does a rumbling NHS crisis erupt into a volcanic political eruption? Labour’s miserable failure to “weaponise” the NHS into a winner in Copeland makes it worth looking back.

Mrs Skeet was the tipping point for Labour. The worst flu epidemic in a decade blew away Tony Blair’s pre-election “waiting lists cut” pledge. Instead Labour stuck to a draconian Tory budget, but this one case sent Blair into the TV studios promising to match average EU spending – and Labour did. The best NHS decade followed: 7% annual budget increases saw waiting times plummet, as heart and cancer results improved.

Margaret Thatcher’s eruption came in 1987 with the NHS squeezed dry. Babies died waiting for operations at the Birmingham Children’s Heart hospital. Through gritted teeth, the NHS “safe in our hands”, she bunged it £100m and punished it with the internal market.

In this latest seismological era, political vulcanologists can’t predict exactly when the top will blow. With its lowest ever funding rises, its hardest years are still to come, despite soaring numbers of the old, hospital admissions up by 31%, and 22% more A&E patients since 2010. Staff shortages follow cuts in nurse training and worsening GP and specialist recruitment. Even if extra is found for social care, the National Audit Office suggests it won’t stem the flow of patients into hospitals.

Are things bad enough yet? The British Medical Association reports that 15,000 hospital beds have been cut in the past six years. The Royal College of Surgeons protests at cancer operations being cancelled. Ambulances frequently stack up outside hospitals. Look at all that molten lava bubbling away.

Mavis Skeet’s death in 2000 became a tipping point for the NHS under Labour. Her operation for cancer of the oesophagus was cancelled four times. Photograph: PA

Ahead of next week’s budget, Theresa May pretends the NHS has an extra £10bn – at loggerheads with Simon Stevens, the head of NHS England, who publicly disputes it. What forces a U-turn? Before it was deaths, but already two patients have died on Worcester Royal hospital trolleys, one after a 35-hour wait. Coroners have protested to the health secretary, Jeremy Hunt, after two recent deaths due to lack of intensive care beds: the case of Teresa Dennett, who died from a stroke, and Mary Muldowney, who died after a brain haemorrhage.

The war zone of A&E has featured nightly on BBC news, with a graphic documentary series on the controlled mayhem in barely coping hospitals. When is enough enough? Not quite yet, it seems. The government has been lucky, with no flu epidemic in any recent winters or any Arctic freeze-over. With beds at full capacity, it would only take a mild outbreak to tip over the NHS.

The pressure-cooker is finance: monumental debts swell by millions a month as hospitals receive absurdly frantic threats if they don’t cut back. In December they were told to free beds by cancelling operations, causing longer waiting times and lost revenue from missed operations. Look at King’s College hospital, in south London: its chair, Bob Kerslake, calls official finances “kidology”. Ordered to make a surplus this year, King’s can’t avoid a £2m loss – yet the punishment is a cut in funds, sending its deficit to £30m, and an instruction to make a £26m surplus next year: this is mirage accounting, mirrored everywhere.

So far these debts are Hunt’s and chancellor Philip Hammond’s problem: what do patients care? But if the Treasury really means to recoup the money, plus the £22bn in savings it demands of the NHS by 2020, then Vesuvius will blow. Wards and units will close, staff will be laid off, the chaos will be unprecedented. It can’t happen.

When the government is forced, kicking and screaming, to pay up, who will it blame? It will call the NHS “unsustainable” and “a bottomless pit”. (Hammond already has.) Yet more “reforms” and re-disorganisations will be hurled at it: payment for services, top-up insurance and tax rebates for private payers will resurface. The government will ignore the UK’s fall in the EU spending scale since 2010, and is now sixth out of the G7 countries, with fewer beds, doctors and nurses per capita.

Who has the political heft and credibility to defend it? Fear of Labour’s NHS moral hegemony kept Thatcher, John Major and David Cameron in check. No longer. Labour thought the NHS was its big bazooka in Copeland, where a maternity unit is under threat. But the naked desperation of Labour’s “Babies will die!” leaflets shot the very last bolt in Jeremy Corbyn’s arsenal. Each time he raises the NHS at prime minister’s questions his feeble attempt at “weaponising” sounds pathetically opportunist: May bats him away with balderdash statistics he is too incompetent to refute.

This has never happened before: polls find May more trusted than Corbyn to run the NHS by 45% to 35%. Far worse, Labour’s failure to counter the right’s message has left more people blaming the NHS crisis on migrants and patients’ bad lifestyles than Tory underfunding or rising numbers of older people. As ever the Mail and the rest carry endless NHS tourism or obese wastrel stories – but Labour has always had to fight twice as hard to get a hearing for the facts on the NHS.

Whoever follows Corbyn will now find it ferociously hard to regain that lost NHS ground. By 1997, hammering away in opposition, Labour had made the threadbare NHS the top issue and owned it. Hard-won economic credibility earned it the trust to run the NHS better. Now Ben Page of Ipsos Mori finds the NHS the second issue after Brexit, but Labour doesn’t own it, or anything else: Corbyn falls behind on everything, with every demographic, so even Labour voters prefer May.

Because the NHS crisis has so far exploded in debt rather than closures, most people’s experience is not yet bad enough to reach tipping point. Page says satisfaction is down on 2010, but not rock bottom, with always a long lag in perception. A third would pay more tax for the NHS, but the rest want savings by denying obese people and migrants.

Austerity has entered the nation’s blood stream: Page finds most people still think it necessary – despite the reckless tax cuts ahead. Banging on about “austerity” without specifics gets Labour nowhere. May’s own polling and her Copeland result tell her this – but hubris is her greatest peril. There may be no opposition, but if she and her chancellor really try to squeeze the gargantuan debt out of the NHS, all hell will break loose anyway.

Labour’s failure on the NHS is prolonging this health crisis | Polly Toynbee

London ambulance staff log calls with pen and paper after IT failure

Staff at one of the country’s biggest ambulance services had to log emergency calls manually overnight because of technical issues in the control room, delaying response times.

It is understood London ambulance service’s computer system crashed, forcing staff to record details of calls by pen and paper for nearly five hours on one of the busiest nights of the year.

A spokeswoman said staff were trained to deal with such situations and were able to prioritise responses to those in greatest need.

The deputy director of operations Peter McKenna said: “Due to technical difficulties, our control room was logging emergency calls by pen and paper from 12.30am to 5.15am.

“Our control room staff are trained to operate in this way and continue to prioritise our response to patients with life-threatening conditions, using the same triage system as usual.

“We also have additional clinicians on duty to offer control room staff clinical advice if it is needed.”

London ambulance staff log calls with pen and paper after IT failure

Failure to meet cancer targets shows the NHS can no longer cope

Everywhere is struggling to cope. The increasing failure to hit the waiting time targets for cancer patients reflects systems that are struggling to meet workloads. Hospitals are struggling to get people’s tests done in time, to get their diagnosis for them as soon as possible and to be able to make plans for their treatment.

Three years ago, hospitals were managing to respond to the needs of people by generally meeting NHS waiting time targets for the growing number of those being referred with suspected cancer. The fact that we were hitting the targets didn’t mean that everything was perfect, but it did indicate that the way the system was organised meant that we were coping and working to meet demand. It doesn’t feel like we are coping any more.

Patients are waiting longer for scans, biopsies, pathology results and for treatment plans to be finalised. We are largely meeting the 14-day target and the target for 31 days from diagnosis to treatment. But we are largely failing to meet the 62-day target. That’s the time between someone being referred by their GP and them having their first definitive treatment. Delays are occurring mainly between a suspected cancer patient seeing a specialist and having a definite plan for their treatment drawn up. Myself and colleagues come across this all the time; people who have waited two, three or four weeks for a CT scan or biopsy.

That matters for individual patients because they have a prolonged period of uncertainty. Do I have cancer or do I not? And if I do have cancer, will it be curable? If it was a private hospital or one of the great hospitals in the US or Europe the consultant could expect to have the answers from the tests within a week. But here it can be as long as a month.

There will be some people who get worse while they are waiting for tests to take place or for the results to come back. Their cancers will grow. In a small proportion of them their cancer may spread. If you look after people with cancer it’s a desperate situation to be asking them to wait for their tests and to be planning to see them after a month because they won’t have their results until then, and we know that’s going to be a month of terrible worry for them.

This failure to meet targets, to keep up with the growing demand for cancer care, was a foreseeable problem – and it’s getting worse. Previously we planned for what we knew was going to be the growing number of people needing tests and treatment. Now we need a lot more radiologists and endoscopists, for example, to keep up with what we know is going to be the even greater numbers of people needing cancer care in the years to come. But now it’s not just the tens of thousands of people who have not been treated within 62 days over the last two and a half years since the NHS nationally began missing that target. It’s the fact that we now have a system that’s failing, and that can’t be acceptable.

• Peter Johnson is professor of medical oncology at Southampton University and Cancer Research UK’s chief clinician

Failure to meet cancer targets shows the NHS can no longer cope

Teenage girls talk about anxiety: "It"s always linked to failure" – video

One in three teenage girls in England and Wales suffers from anxiety, according to a survey of 14-year-olds for the Department for Education. Orli, a 17-year-old girl from north London, talks to her friends about her anxiety, how she plans to beat it and stop the stigma surrounding it

Teenage girls talk about anxiety: "It"s always linked to failure" – video

Secret Teaching: I love teaching, but I"m tired of feeling like a failure

When I began teaching 18 years ago, I poured everything I had into it. I started at a tough inner-city Manchester school. I ran after-school football and film clubs, and produced Shakespeare plays with 8- to 11-year-olds. I was glad to be observed 10 times in a gruelling five-day Ofsted visit (it was 1998). I put so much in and got so much out – I was young, single and I didn’t care about late nights and early mornings.

A few years later I moved to another challenging school down the road, as deputy headteacher. The budget was incredibly tight which meant I had zero management time and taught all week; this was before the luxury of PPA (the time that’s set aside for teachers to do planning, preparation and assessment work). I always had a foot out of the door and an ear cocked for trouble in the corridor – even more so when I spent a term as acting headteacher when the excellent head was in hospital.

I think that’s when my downward spiral started. I’d taken on a class where I had to field chairs being thrown at me, coerce one pupil from the roof and fend off physically abusive parents. I would become frustrated and angry when things went badly (being punched by a parent, the local authority demanding that results improve) and completely elated when things went well (transforming 30% of pupils achieving level 4 into 70%, seeing special educational needs and disaffected year 6 students performing Richard III).

Within three years, I hit a wall. I went back to my hometown, to teach in a successful primary in a leafy, middle-class area. I thought it would give me a chance to work in a less stressful environment. I was wrong. The pressure – in school, from the government and families – was different, but equally debilitating.

It was an outstanding school and the local education authority (LEA) had expectations. “Yours is one of the better schools,” we were told. “For us to reach our target, we need you to up your Sats results, because the other schools in the area are rubbish.” I’m paraphrasing, but the message was clear. I made an initial impact and was expected to carry the year 6 can. It wasn’t the school or the staff’s fault, it’s just the way things were and still are.

Each morning I would wake up feeling sick to my stomach. I spent my lunchtimes alone, sitting outside in the street, struggling to eat the lunch I’d prepared. There was just so much to do.

After a spell in hospital, I was diagnosed with severe depression. School wasn’t the only factor, but it tipped the balance. I was given months off work, saw psychiatrists and other mental-health professionals and had to fight to get back into the classroom nine months later. I managed it (in large part thanks to my now-wife, who I met through this illness) but it was a pyrrhic victory.

The next eight years had some highs – days when I really thought I was “winning” and that I’d taught well – but there were also more lows. There were times when I felt I was sinking; my to-do list was never-ending and parents irrationally expected their children to be level-pegging with their peers without understanding that people children learn at different rates.

When my son was born two years ago, I realised that family is more important to me than the increasingly demanding job that teaching has become. It’s more important than juggling targets and trying to keep up with the latest short-sighted initiative from Whitehall.

Now I’m a supply teacher, and am lucky that I can survive on the money. Half the wages, 10 times the happiness. I don’t plan, I’m home by 4pm and the job just pays the bills. And my mental state is so, so much improved.

I loved teaching and I miss it profoundly. But my mental health means I just cannot juggle all the balls necessary to be good at it. I demand a lot of myself as a teacher and the demands placed on the teaching profession – by local authorities, Whitehall, governing bodies, heads, parents – mean that I feel a failure far more often than I feel that I am of worth.

Secret Teaching: I love teaching, but I"m tired of feeling like a failure

Why can’t our leaders learn from 30 years of failure in health and education? | John Quiggin

The inadequacy of competition and the profit motive in the provision human services like education and health has been established by harsh experience with consistent failures like PFI hospitals, for-profit schools and private prisons. This failure presents a puzzle: how is it that (assuming we have an adequate income) we can rely on for-profit corporations to put food on our tables and clothes on our backs, but not to educate our children or preserve our health.

In the hands of many advocates of privatisation, this puzzle is turned into a knock-down refutation: if the profit motive works well in providing something as vital as food, it must work well everywhere. The latest instance of this naive faith in the market is the Australian Productivity Commission’s call to privatise public health and housing.

In fact, there is no puzzle here: economists and public policy scholars worked out decades ago how to answer this question in principle, and solved many of the issues in detail. The problem is that the political class, along with much of the economics profession, have done worse than the Bourbons, of whom Talleyrand observed “they have learned nothing, and forgotten nothing”. Leading economist Paul Romer recently observed, echoing earlier comments by Robert Gordon, that macroeconomics has been going backwards since the early 1980s.

The same is true of the regressive microeconomics underlying the dogma that privatisation and market competition are always and everywhere beneficial. Our leaders, and the economists who advise them, have shown themselves incapable of learning from experience, but they have forgotten much that we once knew. In this case, what we once knew was the analysis of market failure that supported the successful mixed economy that came into being in the mid-20th century.

The basic analytical framework was set out in Francis Bator’s 1958 article, “The anatomy of market failure”, (itself drawing on earlier work by the great British economist AC Pigou). It was developed further by a string of contributions from economists like Kenneth Arrow, Joseph Stiglitz and George Akerlof, all of whom received the Nobel Memorial Prize in Economic Sciences for their work.

Taken together with Keynesian macroeconomic theory, this body of work explained why a properly functioning modern economy must be one in which some goods and services are provided by firms competing for profit and others by governments or publicly-funded non-profit organisations. The result is the “mixed economy”, political and social aspects of which were analysed by scholars such as Karl Mannheim and Andrew Shonfield.

Human services are among the sectors of the economy where markets and competition perform badly. The central problems related to human services involve information and finance. These are most obvious in relation to education. Education is for most of us, a once-only experience, and its value is hard to assess, except in retrospect. To some extent, we can make choices on the basis of the reputation of schools and universities. However, these reputations change only slowly over decades, so slowly that no rational for-profit firm would invest in maintaining them.

Moreover, education is hugely expensive, so that most families can’t afford it in the absence of public provision or a public subsidy. The experience of for-profit education in Australia and the US has been that it is far easier to extract public subsidies through scams of various kinds than to compete on the basis of high-quality education.

Many of the same issues arise in healthcare. Obviously, if we knew what was wrong with our health and how to fix it, we wouldn’t need doctors to tell us. As it is, we need to rely on the judgment of our doctors to give us the right treatment and, equally importantly, to tell us when we will get better without treatment. The greater the role of profit in the system, the greater the incentive to provide unnecessary or overpriced services. The example of the United States, which spends more on healthcare than any other country, with worse results, is an illustration.

Information isn’t a problem, or not much of one, in the case of food supply. We buy food on a weekly or even daily basis and have plenty of chances to determine what we like, and which suppliers offer good value for our money. There are things we can’t easily observe, like the cleanliness of food preparation, but these can be dealt with through regulation rather than through governments getting into the food supply business themselves.

Of course, none of this helps if you don’t have enough money to afford the food you need. But long experience has shown that the best way to help poor people afford necessities like food is to give them more money. Neither general food subsidies nor welfare payments tied to food purchases (food stamps) have ever worked as well as income redistribution.

If markets and profits don’t work well in the provision of human services, why should we expect governments and non-profit organisations to do any better? The answer is that that non-profit provision relies on professionalism and a service ethos. These can’t be combined with reliance on direct financial incentives and managerial control.

The Bourbons who have dominated public policy for the past few decades are resolutely hostile to any kind of professional or service ethos. They take for granted the most simplistic versions of textbook economics, in which only monetary incentives matter. On a more sophisticated view of the question, people care just as much about the respect of their peers and belief in the value of their work as they do about the size of their pay packet.

This is ultimately an empirical question, and after 30 years of failure we have more than enough evidence to reach a conclusion. Across the human services sector, markets, incentives and competition rarely work better than non-profit provision and frequently lead to disastrous failure.

Why can’t our leaders learn from 30 years of failure in health and education? | John Quiggin

Failure to curb junk food ads ‘will hinder parents’ in fight against obesity

A failure to limit the way the junk food industry promotes itself to young people will make life far harder for parents trying to give children a nutritious diet, according to the royal society set up to improve public health.

Related: Theresa May’s climbdown on obesity is her first big mistake | Jackie Ashley

Experts in child health had hoped that the government’s long-awaited plan for fighting childhood obesity would include a comprehensive commitment to rein in the power of the food industry to advertise its more unhealthy products to children.

But, while the Department of Health is understood to have been supportive of the commitment, it was omitted from the plan unveiled last week during the summer recess following intervention by No 10. The decision dismayed many in the public health sector.

The watered-down plan, nine months in the making, was seen as a major victory for the fast food and fizzy drinks industries which have lobbied vigorously against measures that would stop them advertising at key times. Originally due to be unveiled by David Cameron, the revised plan under Theresa May’s new government has been savaged by TV chef Jamie Oliver and health bodies for not going nearly far enough.

Public Health England had produced a large body of evidence that suggested tackling the way the food and drinks companies target children was vital if the plan was to have an impact. But the government’s decision to ignore the evidence represents a huge missed opportunity, according to Shirley Cramer, chief executive of the Royal Society for Public Health (RSPH), which conducted interviews with children and their parents on what needed to be done.

“Everybody was advocating very hard for a ban on advertising junk food before the watershed and for family-based programmes like The X Factor,” Cramer said. “We’ve done quite a lot of research talking to young people who tell us that this – the stuff they see online, on bus tickets on posters near their school – makes an enormous difference. People are worried about the promotions, about the advertising. It’s all about pester power – 75% of parents we spoke to said their kids had seen an ad and they’d give in after half an hour of pestering.”

Cramer described the government plan as a good one but with “some big bits missing”. Only if a range of relevant government departments were to commit to preventative measures could the mounting problem of childhood obesity be adequately tackled, she suggested.

“If you look at teen pregnancies, that was a committed, longstanding strategy that went on for 10 years and now we’ve got the outcomes that are much better than predicted. If you really mean to do something about childhood obesity you can, but you need to get all these things working at the same time.”

The failure to constrain the advertising power of the fast food industry would make the job of councils trying to fight obesity all the more difficult, Cramer said. “For a local authority trying to take action against child obesity it doesn’t make their life easier. Junk food will still be advertised everywhere. It means the fight against childhood obesity will be much harder.”

She also echoed concerns expressed by some supermarket chains that voluntary plans to reduce sugar amounts in food would fail. “If you make it mandatory then, in a competitive sense, everyone knows where they stand. If it’s voluntary then the companies who do something will feel, ‘well the other guys aren’t doing it’. It needs to be a level playing field. We’ve got to do what we did with salt. The evidence is clear: most kids who are overweight or obese get their calories from sugar-sweetened beverages.”

Nearly 10% of all four- to five-year-olds and almost 20% of 10- to 11-year-olds are obese ,according to official figures. Obesity-related health issues now cost the NHS almost £5bn a year. The RSPH reports that half of all adults are predicted to be obese by 2050, more than doubling NHS costs to £10bn a year and with wider economic costs to the nation of almost £50bn.

“If we can reduce the number of children who are obese and therefore the number of adults who are obese we will not only be saving lives but saving the NHS money,” Cramer said.

Failure to curb junk food ads ‘will hinder parents’ in fight against obesity

Patient died throughout drug trial "because of numerous organ failure"

She was admitted to Royal Shrewsbury Hospital with a chest infection and died of a number of organ failure on August 24 last year following establishing a variety of viral infections. Dr Atheer al-Ansari, a advisor rheumatologist at the Orthopaedic Hospital in Gobowen, Shropshire, who cared for her throughout the trial, mentioned he was “shocked” by her issue and had never observed a patient with 3 such significant infections ahead of.

Mrs Owen, of Coed Y Go, Oswestry, suffered from rheumatoid arthritis and had been taking part in a clinical examine of a new drug, MK8457, to see if it could ease her symptoms.

He assured the hearing that he had created it clear from the commence that she ought to end taking the medication if she suffered any unwell effects.

Nonetheless, Heidi Knight, on behalf of Mrs Owen’s family, claimed that on the weekend she became sick, Dr Ansari informed her to keep taking the pills. He replied: “I spoke to Mrs Owen 3 instances that weekend and repeated that she ought to end the medication.”

He also sent a letter to her GP giving the very same advice.

Mrs Owen was the only Briton out of 60 patients in the globally study, run by a overall health care business referred to as MSD. In accordance to Dr Ansari, none of the other patients had suffered from severe infection.

Dr Catherine Whittall, analysis programme manager at the Orthopaedic Hospital, confirmed Mrs Owen totally understood the hazards and was content to get part. “Mrs Owen in no way expressed any concern about being on the trial and Dr Ansari often stored her up to date with the hazards and positive aspects,” she said.

The inquest heard Dr Ansari had ordered the review to be discontinued and the hospital had considering that carried out its personal inner assessment into the circumstances of Mrs Owen’s death.

John Ellery, the Shropshire coroner, ruled Mrs Owen had died from multi-organ failure due in component to rheumatoid arthritis and its treatment method.

Patient died throughout drug trial "because of numerous organ failure"

Failure to protect women from FGM is "ongoing national scandal", MPs say

As portion of the petition towards FGM, Fahma Mohamed and fellow campaigners gather to meet Michael Gove earlier this 12 months. Photograph: Christian Sinibaldi/The Guardian

The failure of successive governments to protect vulnerable girls from female genital mutilation is an “ongoing national scandal”, according to a report by MPs published on Thursday.

The cross-celebration Commons property affairs decide on committee calls for schools to get rid of funding if their headteachers do not read through advice issued earlier this yr following a Guardian campaign.

Soon after hearing from victims, wellness and social employees, police and attorneys the MPs also explained there was a situation for emulating the French model by checking up regularly on at-danger youngsters,but they stopped quick of endorsing necessary gynaecological checks. It is estimated that 24,000 girls under the age of 15 are at danger of female genital mutilation in the United kingdom.

Keith Vaz, the committee’s Labour chairman, said victims had been badly let down. “FGM is an ongoing national scandal which is probably to have resulted in the preventable mutilation of thousands of ladies to whom the state owed a duty of care,” he said.

“Successive governments, politicians, the police, well being, education and social care sectors need to all share responsibility for the failure in recent many years to react adequately to the developing prevalence of FGM in the United kingdom.”

The MPs welcomed the determination taken by the education secretary, Michael Gove, to publish to all schools in England and Wales warning them of the dangers of FGM, following a Guardian-backed petition attracted more than 230,000 signatures this 12 months.

Even so, the committee members mentioned the Division for Training had to do a lot more to make sure teachers had been informed and need to send the guidance out once again.

The report stated: “To guarantee that the guidance has been looked at, the Division for Education should link the receipt of a proportion of school funding that relates to social training and youngster safety to the electronic notification that the guidance has been viewed.

“We further advocate that headteachers and little one safety officers, where they have not presently done so, undergo compulsory safeguarding education which specifically bargains with FGM.” The MPs also say:

• Any little one seen as becoming at danger of female genital mutilation must have that view regularly recorded in the child’s individual wellness record. Safety orders need to be introduced for individuals at danger…, as well as provisions to make certain women living in the Uk but with no British passports do not slip through the net.

• Much better solutions are essential for survivors, which includes refuges for ladies at danger of female genital mutilation.

• Failure to report female genital mutilation ought to be produced a criminal offence if reporting of the practice does not improve in the subsequent 12 months.

Keir Starmer, the former director of public prosecutions, mentioned the report was a considerable milestone for the campaign to end FGM. “The proposals are far-reaching and will want to be worked by means of, but the recognition that all companies have a duty for FGM prevention and reporting is considerable. Even though prosecutions right after the occasion send a quite crucial message, schooling and instruction to avert FGM in the first location is greater.”

Starmer extra that even though proposals to support victims better, such as anonymity, have been welcome “in the end, the greatest prospect of success in enforcing the law lies with proactive policing and intelligence-led instances”.

Campaigners largely welcomed the pick committee report but voiced aggravation with a lack of some specifics. Lisa Zimmermann, of Integrate Bristol, welcomed the proposal to make training of teachers compulsory. “We are thrilled by the report, education is definitely crucial in placing a quit to FGM – we just hope that the government now acts on these suggestions,” she said.

Efua Dorkenoo, director of the Finish FGM campaign at Equality Now and a long-time campaigner, stated the report was “extremely good” but could have gone additional.”To have the endorsement of the house affairs committee on this is really important and it is the most significant acknowledgement of the issue we have had so far from parliament,” she mentioned. “I would have liked for them to make the failure of pros to report FGM a crime, because there is nevertheless resistance between some specialists – the government wants to make the decision for them.”

Sarah McCulloch, who runs the grassroots anti-FGM charity ACCMUK, said: “The report is wonderful but for me it has failed to give recommendations as to what experts need to do or make the government supply funding for neighborhood groups to tackle the practice on the ground.”

Dr Peter Carter, standard secretary of the Royal School of Nursing, said the RCN was currently in the procedure of updating its personal guidance on FGM. “The report correctly identifies the need for education, advice and assistance to help health care workers talk about this issue with sufferers, determine these who are at chance of FGM, and get proper action,” he mentioned. “It is essential that this momentum is stored up, with improved coaching and help for employees, enhanced awareness, and prosecutions, to send the message that FGM has no place in the United kingdom, or any other society.”

Failure to protect women from FGM is "ongoing national scandal", MPs say

Januvia Linked To Improve in Heart Failure Hospitalizations

The cardiovascular results of medicines utilized for glucose manage in patients with diabetes have been a topic of controversy for numerous years now. Far more just lately, interest has started out to emphasis especially on the risk for heart failure. Now, an observational research will most likely raise new queries about the dipeptidyl peptidase (DPP)-four inhibitor sitagliptin (Januvia, Merck).

In a paper published in JACC Heart Failure, Daniala Weir and colleagues analyzed insurance coverage claims from a database of far more than 7600 patients with diabetes and heart failure. Men and women who took sitagliptin were not a lot more most likely than nonusers to have a primary endpoint event (death or all-lead to hospitalization). Even so, they have been far more most likely to be hospitalized for heart failure (12.5% vs. 9.%, adjusted OR: one.84, CI one.16-two.92).

The authors explained their locating “is likely clinically relevant” and may possibly have an impact on the choice of include-on therapy for heart failure sufferers with diabetes.

In an accompanying editorial, Deepak Bhatt writes that the findings “add to a little but developing body of proof that suggests DPP-four inhibitors as a class of drugs, and perhaps diabetes medication in basic, may boost the threat of heart failure.” However, he mentioned, the “increase in absolute threat, if current at all, seems to be tiny.”

Januvia Linked To Improve in Heart Failure Hospitalizations

ESC Scorching Lines: 1st True Information On Promising Novartis Heart Failure Drug

The initial true particulars about the a lot-anticipated novel new heart failure drug from Novartis Novartis will kick off this year’s Sizzling Line sessions at the yearly meeting of the European Society of Cardiology in Barcelona, Spain. The meeting runs from August 30 right up until September three.

As I have previously reported, the PARADIGM-HF trial was stopped since of a extremely statistically important reduction in cardiovascular mortality in individuals taking LCZ696 (a novel, 1st-in-class Angiotensin Receptor Neprilysin Inhibitor) instead of the existing gold common of remedy, an ACE ACE inhibitor. Until we see the information it is unattainable to attain any conclusions, but it should be mentioned that there would be huge clinical and organization implications if a new drug  becomes a normal of therapy for millions of people with heart failure.

One more presentation that will likely entice a whole lot of curiosity is the SIGNIFY trial with the drug ivabradine, which is marketed in Europe by Servier and is below improvement in the US by Amgen. As I have previously reported, the European Medicines Agency mentioned that it has started out a assessment of the drug primarily based on troubling findings from the trial.

Also confident to entice interest will be two presentations on the new PCSK9 inhibitor alliorcumab beneath development by Sanofi and Regeneron. Chris Cannon will current benefits of the Odyssey Combo II study in high threat patients with inadequately managed hypercholesterolemia on maximally tolerated daily statin. Michel Farnier will present results of the ODYSSEY FH I and FH II scientific studies in patients with heterozygous familial hypercholesterolemia not adequately managed with existing lipid-decreasing treatment.

Right here is the complete record of Sizzling Line trials:

Hot Line: Cardiovascular ailment: novel therapies

• 31 Aug 08:thirty – ten:20


• Chairpersons: Mariell JESSUP (Philadelphia, US), Hector BUENO (Madrid, ES)

08:30 Benefits of the Prospective comparison of ARNI with ACEI to Determine Impact on Worldwide Mortality and morbidity in Heart Failure trial (PARADIGM-HF) Milton PACKER (Dallas, US)

• Discussant: Michel KOMAJDA (Paris, FR)

08:48 A randomized managed trial of vagal stimulation for the remedy of systolic heart failure: NEural Cardiac Therapy foR Heart Failure (NECTAR-HF) Faiez ZANNAD (Vandoeuvre Les Nancy, FR)

• Discussant: John CAMM (London, GB)

09:06 Impact of ferric carboxymaltose on functional capacity in individuals with heart failure and iron deficiency (Verify-HF) Piotr PONIKOWSKI (Wroclaw, PL)

• Discussant:  Harry CRIJNS (Maastricht, NL)

09:24 Cardiac resynchronization treatment with a novel quadripolar lead decreases problems at 6 months: preliminary benefits of the More-CRT trial Giuseppe BORIANI (Bologna, IT)

• Discussant: John CLELAND (London, GB)

09:42 Colchicine for Submit- operative Pericardial Effusion: The post-operative pericardial effusion (POPE-two) Study. A multicenter, double-blind, randomized trial Philippe MEURIN (Villeneuve-St.-Denis, FR)

• Discussant: Jae K OH (Rochester, US)

10:00 COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 trial) Massimo IMAZIO (Torino, IT)

• Discussant: Stavros V KONSTANTINIDES (Mainz, DE)

Sizzling Line: Coronary artery condition and lipids

• 31 Aug 16:thirty – 18:00 Miscellaneous Hot Line Barcelona – Central Village


• Chairpersons: John Gordon HAROLD (Los Angeles, US), Fausto Jose PINTO (Lisbon, PT)

sixteen:thirty The Stabilization Of pLaques Utilizing Darapladib-Thrombolysis in Myocardial Infarction 52 (Reliable-TIMI 52) trial: Main Benefits Michelle O’DONOGHUE (Boston, US)

• Discussant: Robert M CALIFF (Durham, US)

sixteen:48 Ivabradine in patients with steady coronary artery ailment without clinical heart failure: The final results of SIGNIFY Kim FOX (London, GB)

• Discussant: Jean-Pierre BASSAND (Thise, FR)

17:06 Efficacy and security of alirocumab in higher cardiovascular danger individuals with inadequately managed hypercholesterolaemia on maximally tolerated everyday statin: final results from the ODYSSEY COMBO II examine Christopher Paul CANNON (Boston, US)

• Discussant: Thomas Felix LUSCHER (Zurich, CH)

17:24 Efficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolaemia not adequately managed with recent lipid-reducing treatment: results of ODYSSEY FH I and FH II scientific studies Michel FARNIER (Dijon, FR)

• Discussant: Thomas Felix LUSCHER (Zurich, CH)

17:42 The distinctions of the effects on lipid-lowering actions and glucose metabolisms in between rosuvastatin and atorvastatin in Japanese diabetic individuals with hyperlipidemia Hisao OGAWA (Kumamoto, JP)

• Discussant: John CHAPMAN (Paris, FR)

Hot Line: Heart failure: gadgets and interventions

• 1 Sep eleven:00 – twelve:50 Miscellaneous Hot Line Barcelona – Central Village


• Chairpersons: Hisao OGAWA (Kumamoto, JP), Panagiotis VARDAS (Heraklion, GR)

eleven:00 Randomized comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a resilient polymer everolimus-eluting stent for percutaneous coronary revascularization Thomas PILGRIM (Bern, CH)

• Discussant review Patrick SERRUYS (Rotterdam, NL)

eleven:18 Autonomic regulation therapy for the improvement of left ventricular function and heart failure signs and symptoms: The ANTHEM-HF Research Inder ANAND (Minneapolis, US)

• Discussant overview Gerhard HINDRICKS (Leipzig, DE)

11:36 Biventricular pacing for atrIo-ventricular BlOck to Stop cArdiaC dEsynchronization Jean-Jacques BLANC (Brest, FR)

• Discussant assessment Patrick SCHAUERTE (Berlin, DE)

eleven:54 Comparison of appropriate ventricular septal pacing and right ventricular pacing in patinets acquiring a CRT-D Christophe LECLERCQ (Rennes, FR)

• Discussant review Jagmeet SINGH (Boston, US)

twelve:12 Optimal technique and outcomes of catheter ablation of persistent atrial fibrillation: Outcomes of the Potential, Randomized STAR AF 2 Trial Atul VERMA (Newmarket, CA)

• Discussant review Paulus KIRCHHOF (Birmingham, GB)

12:thirty EuroEco (European Overall health Financial Trial on House Monitoring in ICD Sufferers): a provider viewpoint on comply with-up costs and net financial affect of remote monitoring in 6 European nations Hein HEIDBUCHEL (Leuven, BE)

• Discussant review Carina BLOMSTROM-LUNDQVIST (Uppsala, SE)

Hot Line: Myocardial Infarction

• one Sep 16:thirty – 18:00 Miscellaneous Sizzling Line Barcelona – Central Village


• Chairpersons: Lars WALLENTIN (Uppsala, SE), Karl-Heinz KUCK (Hamburg, DE)

sixteen:30 Comprehensive versus Lesion only Principal -PCI Trial (CvLPRIT): Deal with the infarct related artery only or all lesions Anthony H GERSHLICK (Leicester, GB)

• Discussant review Shamir R MEHTA (Hamilton, CA)

16:48 In-ambulance versus in-cath lab administration of ticagrelor in STEMI individuals transferred for major PCI: the randomized, double-blind ATLANTIC research Gilles MONTALESCOT (Paris, FR)

• Discussant review Paul Wayne ARMSTRONG (Edmonton, CA)

17:06 The British Heart Basis Fractional Flow Reserve versus Angiography in Guiding Management to Optimise Outcomes in Non-ST-Section Elevation Myocardial Infarction Colin BERRY (Glasgow, GB)

• Discussant overview Bernard DE BRUYNE (Aalst, BE)

17:24 Nitric oxide for inhalation to decrease reperfusion damage in acute st-elevation myocardial infarction

• Discussant evaluation Michael MARBER (London, GB)

17:42 Impact of intravenous TRO40303 as an adjunct to principal percutaneous coronary intervention for acute ST-elevation myocardial infarction: Results of the MITOCARE review Dan ATAR (Oslo, NO)

• Discussant assessment Hans Erik BOTKER (Aarhus N, DK)

Sizzling Line: Coronary artery disease and atrial fibrillation

• 2 Sep 11:00 – 12:30 Miscellaneous Sizzling Line Barcelona – Central Village


• Chairpersons: Keith FOX (Edinburgh, GB)

eleven:00 Perioperative statin treatment in cardiac surgical treatment for the prevention of atrial fibrillation and perioperative myocardial harm: the Statin Treatment In Cardiac Surgical procedure (STICS) Trial Barbara CASADEI (Oxford, GB)

• Discussant evaluation Paulus KIRCHHOF (Birmingham, GB)

eleven:18 The X-VERT Trial: A comparison of oral rivaroxaban once everyday with dose-adjusted Vitamin K Antagonists in individuals with nonvalvular atrial fibrillation undergoing elective cardioversion Riccardo CAPPATO (San Donato Milanese, IT)

• Discussant overview Christoph BODE (Freiburg, DE)

eleven:36 Recurrence of arrhythmia following quick-term oral AMIOdarone right after CATheter ablation for atrial fibrillation: A double-blind, randomized, placebo-controlled research Stine DARKNER (Copenhagen, DK)

11:54 Impact of large-intensity statin treatment on atherosclerosis in patients with ST-elevation myocardial infarction: Final results of the prospective, longitudinal intravascular ultrasound adhere to-up review Lorenz RABER (Bern, CH)

• Discussant overview Steven E NISSEN (Cleveland, US)

12:twelve IMPI Steroid Review: A Trial of Adjunctive Prednisolone in Tuberculous Pericarditis Bongani Mawethu MAYOSI (Cape Town, ZA)

ESC Scorching Lines: 1st True Information On Promising Novartis Heart Failure Drug

Schoolgirl sent home to rest was dying of a number of organ failure

The schoolgirl, who had not been able to eat or drink for 19 days and weighed just six stones, begged doctors not to send her property, even telling them “I am dying.”

In spite of this, she was sent back to her family members home in in Stourport-on-Severn, Worcestershire, with the rash spreading across her total entire body.

Following he condition continued worsened her father Richard Carter, 48, took her back to hospital the following day but an A&ampE medical professional sent her residence for a 2nd time following testing her oxygen amounts.

Miss Carter was rushed back to hospital two days later on on Christmas Eve the place she then suffered 4 heart attacks and numerous organ failure.

She died at 3pm in front of her mother and father and sister Samantha, 21, who watched helplessly as repeated resuscitation attempts failed.

An inquest in July 2010 heard she had designed a lethal mixture of circumstances in no way prior to noticed in a patient.

Now Mr Carter and his wife Jacqueline, 52, have acquired a “substantial” out of court settlement from Worcestershire Acute Hospitals NHS Believe in.

The mothers and fathers, who run pet outlets across Worcestershire, criticised NHS doctors for letting their daughter down.

They said they have been still angry bosses had refused to make an admission of formal liability in spite of accepting that if Miss Carter had not been discharged, she would most likely have survived.

Mr Carter explained they had been disappointed they had not acquired an apology from the Trust.

He added: “Our loved ones has been utterly devastated at dropping Amy, we have genuinely struggled to come to terms with what has took place.

“We truly feel that the treatment method Amy obtained at hospital fell nicely below acceptable specifications.

“You beat oneself up. As parents you feel I ought to have been accountable for her but you trust the medical professionals.

“On reflection now this is what we now beat ourselves up about, we believe we must have insisted.

“But at the time you don’t believe you can, we presumed she was on the correct side of it and would get greater and trusted the medical professionals.

“Our outlook on life is totally different, which is what it does to you. They will just carry on and we are left to choose up the pieces.

“We place our faith into the clinicians that had been looking following her in hospital and now we have to reside with the guilt of contemplating we could have completed more to conserve her existence.

“We have been fighting for justice for Amy ever considering that she died and the settlement from the Trust marks the finish of a long legal battle.

“Nevertheless, we are bitterly disappointed that they did not totally accept any responsibility for what occurred to our daughter and were unable to provide us with any thorough explanation of what went incorrect.

“With no this details, the reality is that we have no faith that the same tragedy can by no means be repeated.

“Our lives have been turned upside down since 2009 and as a loved ones we no longer celebrate Christmas as it marks the anniversary of us dropping Amy.

“We hope that by way of Amy’s situation lessons are learnt by healthcare staff in recognising when patients need to have more remedy rather than being sent home in the hope no other family has to go through what we have.”

Health-related specialists at Irwin Mitchell attorneys who represented the loved ones located that Miss Carter should not have been discharged on December 21, 2009.

They discovered the bacterial condition she created as a complication of a serious episode of glandular fever would have been spotted if she had remained in hospital.

As an alternative she was permitted house and an overpowering volume of bacteria entered her bloodstream leading to septicaemia which resulted in a speedy deterioration and Amy creating multi-organ failure.

Worcestershire Acute Hospitals NHS Believe in maintains their determination to discharge the teenager was correct.

But medical professionals located hospital workers sent Amy home regardless of her dad and mom raising issues that she was unable to walk since she was so weak.

She had also misplaced over half a stone in fat, was suffering from a large temperature and had created a widespread rash more than her entire body.

Mrs Carter said she was in “disbelief” when her daughter was permitted property because her she had asked doctors if she was going to die just a day earlier.

She extra: “I was shocked due to the fact I was contemplating how am I going to treat her when we get house.

“It was just disbelief. Considering the problem she was in, we did not count on her to go home.

“She couldn’t eat or drink. We were concerned she hadn’t improved, she had got worse if anything. She was dismissed in the morning but we did not go house until the evening.

“I was going to the nurses telling them that the rash was even now vibrant and she was obtaining problems breathing.

“She had asked if she was going to die just the day prior to she was allow home, which is how bad she felt.”

Thomas Riis-Bristow, a healthcare law and patient’s rights lawyer at Irwin Mitchell, additional: “Ever given that Amy’s death the family members have been desperate for solutions about whether or not far more could have been completed to save her.

“They are disappointed that the Believe in has produced no formal admission of liability, in spite of accepting that if Amy had not been discharged, she would have survived.

“Practically nothing can flip back the clock, but the settlement at the quite least, marks the conclusion of the family’s long legal battle to secure justice for Amy’s memory.

“We hope that any shortcomings the Trust discovered in its own internal investigation into the therapy given to Amy are enhanced to avert any long term deaths in related conditions.”

Schoolgirl sent home to rest was dying of a number of organ failure

Labor rejects tobacco industry claim of plain packaging policy failure

Labor has rejected tobacco sector figures that display more cigarettes are becoming sold considering that the introduction of plain packaging.

The tobacco business British American Tobacco Australia has jumped on the figures as proof the plain packaging policy has failed but they are contradicted by Australian Bureau of Statistics information as effectively as by preliminary research into the affect of plain packaging on smoking routines. Labor launched necessary plain packaging in 2012 to significantly protest from tobacco companies.

Figures from InfoView, which are backed by the cigarette businesses Philip Morris and BATA, ran on the front webpage of the Australian on Friday, displaying an improve of .3% in the volume of cigarettes getting offered, but have not been adjusted to account for population development. The study also showed the yearly decline in the amount of men and women smoking more than halved.

When Guardian Australia contacted InfoView for the information it was directed to BATA, who sent a press release quoting the figures and slamming plain packaging.

“With development in sector volumes, fewer individuals quitting and a leap in the amount of cheap illegal cigarettes on the streets, you could draw the conclusion that folks are really smoking far more now than prior to plain packaging came into effect,” a spokesman, Scott McIntyre, stated.

When asked to present the raw information of the analysis, McIntyre replied it was “commercially sensitive”.

“It’s not BATA study,” he stated. “It’s purchased from third-celebration suppliers Roy Morgan and InfoView. We acquire data about our products, just like any other company that sells quick-moving consumer goods.”

Australian Bureau of Statistics figures demonstrate a decline in smokers in Australia since 2001, a trend that continued in 2011-twelve, when the percentage of female smokers dropped to 16.three% and male smokers decreased to twenty.four%.

ABS figures also record a decline in the total home expenditure on tobacco and cigarettes.

South Australia has recorded an improve in the smoking fee in the past 12 months, with 19.4% of the population smoking, up from 16.seven%, in accordance to government figures. The state is in the approach of banning smoking in alfresco places which the government is hoping will help reduced the rate.

The opposition wellness minister, Catherine King, referenced the ABS figures when commenting on the sector figures.

“Only the tobacco market thinks plain packaging is a poor factor – that is because they know they will be selling fewer cigarettes to fewer people,” she mentioned. “It is incumbent on the government to express its unqualified assistance for plain packaging.”

In BATA’s release it explained it was “very clear all information available” in excess of the past 12 months showed the plain packaging policy was a failure.

Most researchers agree it is as well early to correctly measure the impacts of the policy but preliminary investigation has shown men and women have been turned off by the plain packaging, which demonstrates graphic photos of effects of smoking, this kind of as rotting teeth.

Analysis into the influence of the initial 3 months of the policy, published in the British Medical Journal and funded by Cancer Council Victoria, identified 30.6% of smokers utilizing plain packaging perceived their cigarettes to be of decrease top quality than a yr earlier, in contrast with 18.1% of smokers using branded cigarettes.

It was also reported that 26.2% of plain-package smokers were much less satisfied by their cigarettes than they have been a year earlier, in contrast with 14.9% of branded-packet smokers.

Labor rejects tobacco industry claim of plain packaging policy failure

Defibrillators Identified Effective In Much less Significant Heart Failure Individuals

ICDs are routinely implanted in heart failure sufferers with ejection fractions (EFs) of 35% and decrease to stop sudden cardiac death. Nevertheless, the benefits in individuals at the increased end of the spectrum– amongst 30% and 35%– have not been nicely demonstrated in clinical trials, since number of patients in this assortment have been enrolled in clinical trials.

Now a new review published in JAMA suggests that the rewards in this group are comparable to the advantages in heart failure patients with a lot more severely depressed EFs.

Sana Al-Khatib and colleagues analyzed information from the NCDR ICD registry and the GTWG-HF database and in contrast the mortality benefit related with ICDs in individuals with EFs in between thirty% sand 35% with those in sufferers with EFs beneath thirty%. At followup the ICD-associated reduction in mortality was equivalent in the two groups. At three many years the adjusted mortality charges in the EF thirty%-35% have been 47.1% in the ICD sufferers versus 58% in the patients without ICDs. In the EF &lt30%  group the charges were 46.1% and 57%. The hazard ratio for ICD individuals with EF 30%-35% was .83 (CI .69 – .99, p = .04). The HR for ICD sufferers with EF &lt30% was .72 (CI .65 – .81, p &lt .001).

The authors wrote that their findings “support guidelines’ recommendations to implant a prophylactic ICD in eligible individuals with an LVEF of 35% or less.” Though “the big difference in absolute danger by 3 many years was not large (three.six% at 3 years), it was significant and near in magnitude to what was observed in the clinical trials of prophylactic ICDs.”

Defibrillators Identified Effective In Much less Significant Heart Failure Individuals

FDA Approves Novel Implanted Sensor To Monitor Heart Failure

The FDA announced these days that it had authorized the CardioMEMS Champion HF Technique. The small implantable device offers daily pulmonary artery strain measurements to guidebook doctors in their therapy of  NYHA Class III heart failure individuals who have been hospitalized for heart failure in the preceding 12 months. The program consists of 3 elements: a tiny everlasting sensor implanted in the pulmonary artery, a catheter-based mostly delivery technique, and a method that acquires and processes PA pressure measurements from the implanted keep track of and transfers the information to a secure database.

CardioMems had a rocky street to approval. Two separate instances, in 2011 and in 2013, the FDA’s Circulatory Program Units Panel agreed that the device was safe but that it had not been proven to be powerful or that the positive aspects of the device outweighed the hazards. Most of the discussion revolved all around the pivotal CHAMPION trial which enrolled 550 heart failure sufferers. The FDA explained today that it “believes that there is sensible assurance that the device is safe and successful for heart failure management with the goal of reducing the rate of heart failure-associated hospitalizations in specific sufferers.”

The FDA stated that it would need CardioMems to conduct “a thorough Publish-Approval Examine to continue to learn about the device’s efficiency when used outdoors the context of a clinical research.”

CardioMEMS was founded by cardiologist Jay Yadav, who is also the company’s CEO. The firm is partly owned by St. Jude Healthcare, which has mentioned that it ideas to entirely acquire the company in the first half of 2014.

“Heart failure is one of the most typical causes for hospitalizations for folks aged 65 and older,” mentioned Christy Foreman, director of the Office of Gadget Evaluation in the FDA’s Center for Units and Radiological Health, in an FDA press release. “The goal of this very first-of-its-sort implantable wireless gadget with remote monitoring of pulmonary artery pressure is to lessen heart failure-connected hospitalizations.”

There is widespread agreement that heart failure signify an massive and increasing burden on the well being care program. CardioMems cites American Heart Association estimates that direct and indirect expenses of heart failure in 2012 equalled $ 31 billion. However, it is unclear no matter whether the gadget will be capable to fulfill the high expectations suggested in this statement from a CardioMems representative:

Not only is this FDA approval going to influence the quality of lifestyle for patients, it will also conserve up to 40% in Medicare expenditures related to heart failure, which is the largest part of the Medicare price range.

FDA Approves Novel Implanted Sensor To Monitor Heart Failure

Sleeping tablet chance for heart failure patients

The findings have been presented at the Heart Failure Congress in Athens, Greece.

Dr Masahiko Setoguchi said: “Sleeping problems are a frequent side impact of heart failure and it is widespread for sufferers to be prescribed sleeping pills when they are discharged from hospital.

“Our review clearly shows that sleeping drugs significantly improve the chance of cardiovascular occasions in patients with heart failure with preserved ejection fraction.

“Offered that a lot of heart failure individuals have difficulty sleeping, this is an situation that requirements further investigation in bigger research.”

The study was little and only examined health care information of 11 heart failure patients admitted to Tokyo Yamate Health-related Center from 2011 to 2013 so the final results need to be replicated in bigger research before physicians and individuals can be suggested about the safety of sleeping tablets.

The findings relate to patients with heart failure with preserved ejection fraction, which means they have damage to the heart muscle offering them heart failure but the sum of blood pumped out of the left part of the organ with each beat is typical.

There are about 220,000 individuals in Britain with heart failure with preserved ejection fraction, in accordance to figures from the British Heart Basis.

The review located that these individuals had been who were taking benzodiazepine sleeping tablets, which in the United kingdom contain temazepam, loprazolam, lormetazepam, and nitrazepam, had been eight instances more most likely to be readmitted to hospital or die from heart troubles inside of 6 months than individuals with the very same issue who have been not taking the drugs.

There are close to 11m prescriptions for benzodiazepines dispensed in England every year.

Dr Setoguchi explained: “The main finding of our examine is that HFpEF patients prescribed sleeping drugs have an improved threat of cardiovascular occasions. The number of HFpEF sufferers is increasing and turning out to be a larger proportion of heart failure patients general. Our benefits consequently are of growing relevance to heart failure sufferers and the professionals who deal with them.”

He added: “Benzodiazepine hyptonics may possibly have cardiodepressant actions. They might also exert respiratory depressant actions which could exacerbate sleep disordered breathing and lead to a worse prognosis.

“Our results require confirmation in greater, potential scientific studies ahead of heart failure patients can be recommended to cease taking sleeping tablets. But HFpEF sufferers who use sleeping pills, notably those who have sleep disordered breathing, ought to be carefully monitored.”

Sleeping tablet chance for heart failure patients

FDA Rejects Novel Novartis Drug For Acute Heart Failure

Novartis Novartis said today that the FDA had issued a full response letter for the biologics license application for RLX030. The drug, also identified as serelaxin, is a recombinant form of the naturally taking place human hormone relaxin-two, which has been identified to assist ladies modify to the cardiovascular changes that arise during pregnancy.

The FDA selection was not unexpected considering that earlier this 12 months its Cardiovascular and Renal Medicines Advisory Committee voted unanimously towards approval. The rejection occurred despite the reality that the drug received a ”breakthrough therapy” designation from the FDA final yr. Serelaxin was also turned down for approval in Europe earlier this yr.

Novartis mentioned it plans to carry on advancement of the drug. ”We continue to feel RLX030 has the potential to be an essential treatment method for AHF and have been encouraged by feedback from FDA advisory committee members noting the information are intriguing,” explained a business executive. “In accordance with the FDA’s tips we will carry on to expedite our clinical trial system to construct the supporting physique of proof.”

The BLA relied heavily on data from the the pivotal phase III Loosen up-AHF research. Novartis stated it was “continuing to expand the data supporting the efficacy of RLX030 in acute heart failure with an comprehensive global clinical plan, like the Relax-AHF-two trial which will enroll more than 6,300 sufferers.”

FDA Rejects Novel Novartis Drug For Acute Heart Failure

NHS hit by new tech failure as it scraps patient booking technique

MPs were told by NHS staff that even though some GPs liked Decide on and Guide, a lot of did not, and that not all appointment slots were obtainable on it. Photograph: MBI /Alamy

The NHS is quietly ditching an electronic booking system for outpatient appointments, Decide on and Book, which has price £356m given that 2004, in a even more signal of the issues of introducing efficient IT programs into the well being support.

The choice to replace it with a possibly even more pricey e-referral scheme by 2016 follows a drop in its use by medical doctors and sufferers.

Throughout a latest investigation into NHS waiting occasions by the Home of Commons’ public accounts committee, MPs had been told by NHS staff that while some GPs liked Select and Book, many did not, and that not all outpatient appointment slots have been offered on it, limiting its usefulness.

NHS England said final evening the new e-referral method would use different technological innovation, but it was unable to say how significantly the scheme would price.

Meg Hillier, a Labour member of the committee, explained: “It is yet another NHS cock up. A system designed for use by GPs but only used by half of them … has been quietly dropped, so quietly that even most of the NHS would seem unaware.

“In the middle of all of this are individuals. Choose and Guide was supposed to velocity factors up but the proof we heard in committee showed this was not so in most circumstances.”

Choose and Book was introduced by the Labour government to enable patients needing an outpatient appointment to select, with their GP, a hospital appointment at a practical date and time. The aim was to pace up the procedure and lower out the want for pricey paperwork.

The Division of Overall health desires sufferers to turn into a lot more concerned in managing their appointments. The National Audit Workplace has estimated that one.6m patients failed to turn up for first outpatient appointments in 2012-13, costing the taxpayer up to £225m.

But several patients and medical professionals located Decide on and Book complex and time-consuming. Tory MP and former GP Sarah Wollaston said the method suited individuals who had been excellent with engineering but not these who had been much less so. She explained doctors often did not have time to log on to it throughout appointments with their patients.

Wollaston, a member of the Commons choose committee on health, additional that technology could have disadvantages.

“You do have to be cautious that when setting up this type of method utilizing the most current techology, that you do not inadvertently end up widening wellness inequalities in the approach.”

Una O’Brien, the long lasting secretary at the Department of Health, stated the substitute scheme would have further attributes, and would be be available on mobile apps.

She informed the Commons committee: “We are aiming to have a hundred% electronic referrals within the subsequent 5 years – sooner than that if we can make it. That will cut out a good deal of these errors.” The idea of generating it compulsory for GPs to use the substitute program when it comes on stream, with an inbuilt incentive and penalty scheme for doctors and hospitals, is becoming regarded.

The choice to drop Decide on and Book, and admissions that it was not becoming employed by many doctors and patients, marks the most current of numerous IT failures in the NHS, exactly where attempts to embrace technologies in the quest for far more joined-up care have encountered several delays and price overruns.

A £12bn venture launched in England in 2002 aimed to let 50 million patients’ records to be held electronically so that they could be accessed by employees in distinct elements of the services: principal care, hospitals, out of hours solutions and ambulance crews. But it was scrapped by the coalition following a series of setbacks.

NHS hit by new tech failure as it scraps patient booking technique

Heart failure situations do not get expert care, doctors warn

Placing heart failure sufferers on basic wards can delay the commence of medicine, professionals say. Photograph: Alamy

Sufferers with heart failure are dying simply because they receive inadequate care soon after being “scattered” close to hospitals which have also number of beds for them in expert wards, medical doctors are warning.

Heart professionals are concerned that many of individuals with the issue can stay undiagnosed or not get put on the proper medication because they are not taken care of on cardiology wards and looked right after by a committed staff.

Half of this kind of patients finish up on some other kind of ward and have a 54% better opportunity of dying in hospital as a consequence, according to a current audit by specialists of the NHS’s dealing with of practically 44,000 hospital admissions for acute heart failure in England and Wales in 2012-13. Although seven% of individuals treated on a cardiology ward die in the course of their remain in hospital, that rises to 11.three% of those cared for on a standard health-related ward and 14.4% of individuals looked following on any other sort of ward.

Heart failure is typically fatal. One in 4 folks who are hospitalised due to the fact of it die inside a yr of their therapy.

A lot more than 750,000 folks suffer from it. Most are over 65. It takes place when someone’s heart is so weak or stiff that it can no longer pump blood effectively all around their body, leaving them quite out of breath, unable to undertake fundamental each day tasks, and typically with a hazardous develop-up of fluid in their lungs.

“Some individuals are dying unnecessarily,” explained Dr Lisa Anderson, a advisor cardiologist specialising in heart failure at St George’s hospital in south London. “Although care has enhanced in current many years we aren’t treating these individuals appropriately to minimize their probabilities of readmission and death.”

Her very own hospital has between 50 and 60 inpatients with heart failure at any 1 time. However, only “a tiny proportion” finish up on cardiology wards, with the rest spread across as numerous as twenty diverse wards in three various wings, which includes surgical, elderly care and post-operative card wards. That is normal of the situation in many hospitals, Anderson added.

“Individuals get sent just wherever a bed is accessible”, even however they want rapid and ongoing care from heart professionals. Even though someone on a cardiology ward has an echocardiogram accomplished within 24 hours, these elsewhere can wait for up to four days, she stated. That is critical due to the fact it can delay the patient’s diagnosis and therefore currently being place on the proper medication.

Individuals on non-specialist wards are considerably much less most likely to get one particular, two or all three of the various kinds of medicine which improve patients’s odds of survival, thereby raising their danger of death, the audit discovered. Only about one in three of individuals who require to take all three medicines get them.

“All these worrying factors – in which you remain in hospital, when you get your diagnosis and no matter whether you obtain the right medicine – suggest that there is an elevated risk of death if you are not looked following by a professional,” Anderson extra.

Ageing and enhanced care of heart failure – mortality has been halved in the final decade – mean that hospital admissions due to the fact of it shot up by 18% among 2011-12 and 2012-13 in what Anderson named “a massive tidal wave of admissions”. That spike has coincided with cuts in hospital bed numbers in a lot of places.

Professor Peter Weissberg, medical director of the British Heart Foundation, said he shared the concern about patients’ outcomes in non-professional wards but that the sheer number of this kind of individuals meant it was “utopian” to expect hospitals to deal with each 1 on a cardiology ward.

But hospitals need to always have a professional ward for heart failure sufferers – several do not – and a crew of specialist physicians and nurses who can visit people who are elsewhere to guarantee they get excellent care to decrease their danger of death, he stated.

An NHS England spokeswoman mentioned: “There have been tremendous falls in deaths from heart condition in current years, and far better prevention and help at house will support minimize heart failure, but for individuals patients who do in the end need to have inpatient care we certainly want them to get the ideal focus attainable.”

The National Institute for Well being and Care Excellence (Nice) last week mentioned that all heart failure patients must be handled on a cardiology ward as they can acquire inferior therapy if they do not.

Heart failure situations do not get expert care, doctors warn